Zachary Bogue Recursion Pharmaceuticals, Inc. (RXRX) insider trading activity

Zachary Bogue is Director of RECURSION PHARMACEUTICALS, INC.. Currently has a direct ownership of 9,378 shares of RXRX, which is worth approximately $53,454. The most recent transaction as insider was on Jul 03, 2023, when has been sold 1,440 shares (Class A Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.38K

0% 3M change

0% 12M change

Total Value Held $53,454

Zachary Bogue Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 03 2023	BUY Grant, award, or other acquisition	-	1,440 Added 13.31%	9,378 Class A Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	1,542 Added 16.27%	7,938 Class A Common Stock
Jan 03 2023	BUY Grant, award, or other acquisition	-	1,407 Added 18.03%	6,396 Class A Common Stock
Oct 03 2022	BUY Grant, award, or other acquisition	-	977 Added 16.38%	4,989 Class A Common Stock
Jul 01 2022	BUY Grant, award, or other acquisition	-	1,260 Added 23.9%	4,012 Class A Common Stock
Apr 01 2022	BUY Grant, award, or other acquisition	-	1,382 Added 33.43%	2,752 Class A Common Stock
Jan 03 2022	BUY Grant, award, or other acquisition	-	589 Added 30.07%	1,370 Class A Common Stock
Oct 01 2021	BUY Grant, award, or other acquisition	-	295 Added 27.42%	781 Class A Common Stock
Jul 01 2021	BUY Grant, award, or other acquisition	-	295 Added 50.0%	295 Class A Common Stock

Zachary Bogue

Director

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RXRX shares.

Notify only if

Value

Insider Trading

Get notified when an Recursion Pharmaceuticals, Inc. insider buys or sells RXRX shares.

Notify only if

Operation

Value

Type

News

Receive news related to RECURSION PHARMACEUTICALS, INC.

Track Activities on RXRX

Account